Condition: Breast Cancer · Triple Negative Breast Cancer · ER+ Breast Cancer · Sponsor: Royal Marsden NHS Foundation Trust
BELIEVE is a translational research study that aims to collect samples of breast cancer tissue and blood from individuals undergoing breast cancer treatment (such as chemotherapy, targeted therapy and immunotherapy) before surgery. In certain cases, MRI scans and stool samples will also be obtained before and during treatment. The samples collected from this study will be used for molecular and genetic research to understand why some cancers respond very well to anticancer treatments, and some do not, develop novel ways of accurately measuring response during treatment, as well as identify which patients are at a higher risk of the cancer coming back after surgery.
This description comes directly from the study's public registry record.
BELIEVE Trial Manager · 02078082887 · BELIEVE@rmh.nhs.uk
Sophie Cooke · 02034373610 · sophie.cooke@rmh.nhs.uk
Always discuss trial participation with your own doctor first.
| Royal Marsden NHS Foundation Trust | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06681064